AGEN.NASDAQAgenus INC

Form 4: Agenus Inc. Insider Trades Common Stock

Sentiment:

Statement of Changes in Beneficial Ownership


Garo H. Armen, Director and Officer of Agenus Inc., acquired 5,364 shares of common stock valued at $3.03 per share, with salary paid in stock.

Summary

  • Garo H. Armen, a Director and Officer of Agenus Inc., acquired 5,364 shares of common stock on June 26, 2026.
  • The acquisition was made in lieu of cash salary, with shares valued at the closing price of $3.03 on that date.
  • Following this transaction, Mr. Armen beneficially owns 366,256 shares directly.
  • Additionally, he holds 28,950 shares indirectly through IRA accounts and 23,950 shares as trustee for the Garo Armen 2020 2 Year AG GRAT.
  • He also has an indirect interest in 5,000 shares held by Pixie Partners, a General Partnership, though he disclaims beneficial ownership of a portion of these shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it primarily reports on routine executive compensation adjustments rather than significant strategic shifts or financial performance indicators.

Positives

  • Company is utilizing stock to compensate executive leadership, potentially conserving cash.
  • Executive leadership is demonstrating confidence by receiving compensation in company stock.
  • The shares issued for salary are fully vested upon issuance, providing immediate benefit to the executive.

Negatives

  • The filing indicates a portion of executive compensation is being paid in stock, which could imply cash flow constraints or a strategic decision to preserve cash.
  • The value of the stock received is tied to the market price on the transaction date ($3.03), exposing the executive to market fluctuations.

Risks

  • The value of the shares received as salary is subject to market volatility.
  • Indirect beneficial ownership through various entities and accounts introduces complexity in tracking ultimate beneficial ownership.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, which primarily reports on a change in beneficial ownership.

Management Comments

  • At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash.
  • The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending June 26th, 2026.
  • Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.
  • Dr. Armen is trustee and has investment authority for the Garo Armen 2020 2 Year AG GRAT holder of 23,950 shares of our Common Stock.
  • Dr. Armen is a general partner in Pixie Partners, a General Partnership ("Pixie"), which as of the date of this report owns 5,000 shares of our Common Stock.
  • Dr. Armen has a pecuniary interest in only a portion of the shares held by Pixie and disclaims beneficial ownership to the extent of his pecuniary interest therein.

Industry Context

StockSavvy.ai notes that the practice of paying executive salaries in stock is common in the biotechnology and pharmaceutical sectors, particularly for companies focused on development and research where cash conservation is often a priority. This allows companies to retain capital for R&D while aligning executive interests with shareholder value.

Related Party Transactions

  • Garo H. Armen's salary being paid in stock, approved by the Agenus Inc. Compensation Committee.

Stakeholder Impact

  • Shareholders: The issuance of stock for salary may dilute existing share ownership slightly, but also aligns executive interests with stock performance.
  • Employees: May signal a company culture that prioritizes equity-based compensation and potentially cash conservation.
  • Management: Garo H. Armen receives compensation in stock, directly linking his financial benefit to the company's stock performance.

Next Steps

  • Continued reporting of changes in beneficial ownership as required by SEC regulations.

Key Dates

DateDescription
06/26/2026Transaction Date for acquisition of common stock and end of payroll period for which salary was paid in stock.
06/29/2026Date of signature for the filing.

Keywords

Form 4, Insider Trading, Agenus Inc., AGEN, Common Stock, Executive Compensation, Beneficial Ownership, Stock Issuance, Garo H. Armen

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.